Nccam/nci phase 1 study of mistletoe extract and gemcitabine in patients with advanced solid tumors

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Mansky, Patrick J ^a,b   Wallerstedt, Dawn B ^c   Sannes, Timothy S ^d   Stagl, Jamie ^e   Johnson, Laura Lee ^b   Blackman, Marc R ^f   Grem, Jean L ^g   Swain, Sandra M ^h   Monahan, Brian P ⁱ  

^a Bellin Health   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Samuelli Institute   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^h WASHINGTON CANCER INSTITUTE   (United States)

ⁱ Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ANTIBODY; GEMCITABINE; IMMUNOGLOBULIN G ANTIBODY; VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN;

ACUTE KIDNEY FAILURE; ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELLULITIS; CHILL; CLINICAL ARTICLE; COLORECTAL CANCER; CONVALESCENCE; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA MULTIFORME; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; GRANULOCYTE; HUMAN; HYPERGLYCEMIA; HYPOALBUMINEMIA; HYPOCALCEMIA; HYPONATREMIA; INJECTION SITE INDURATION; INJECTION SITE REACTION; LEUKOPENIA; LUNG CANCER; LYMPHEDEMA; LYMPHOCYTE COUNT; MALE; MAXIMUM TOLERATED DOSE; MYALGIA; NAUSEA; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL COUNT; PANCREAS CANCER; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RASH; RIGOR; SIDE EFFECT; SKIN FIBROSIS; SKIN PAIN; STATISTICS; SURVIVAL TIME; THROMBOCYTOPENIA;

EID: 84888592944     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/964592     Document Type: Article

References (46)

1. Elluru S., van Huyen J. D., Delignat S., Prost F., Bayry J., Kazatchkine M. D., Kaveri S. V., Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador. Arzneimittel-Forschung 2006 56 6 461 466 2-s2.0-33748648362 (Pubitemid 44763354)
2. Steiner R., Geisteswissenschaft und Medizin 1985 Dornach, Switzerland Rudolf Steiner
3. Hostanska K., Hajto T., Spagnoli G. C., Fischer J., Lentzen H., Herrman R., A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Natural Immunity 1995 14 5-6 295 304 2-s2.0-0029548382 (Pubitemid 26343562)
4. Stein G., Berg P. A., Non-lectin component in a fermented extract from Viscum album L, grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro. European Journal of Clinical Pharmacology 1994 47 1 33 38 2-s2.0-0028022566 (Pubitemid 24281308)
5. Rentea R., Lyon E., Hunter R., Biologic properties of Iscador: a Viscum album preparation. I. Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following X-irradiation. Laboratory Investigation 1981 44 1 43 48 2-s2.0-0019350036 (Pubitemid 11191655)
6. Beuth J., Ko H. L., Tunggal L., Steuer M. K., Geisel J., Jeljaszewicz J., Pulverer G., Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1. In Vivo 1993 7 5 407 410 2-s2.0-0027494228 (Pubitemid 23359874)
7. Kuttan G., Tumoricidal activity of mouse peritoneal macrophages treated with Viscum album extract. Immunological Investigations 1993 22 6-7 431 440 2-s2.0-0027496960 (Pubitemid 23326243)
8. Hamprecht K., Handgretinger R., Voetsch W., Anderer F. A., Mediation of human NK-activity by components in extracts of Viscum album. International Journal of Immunopharmacology 1987 9 2 199 209 2-s2.0-0023101045 (Pubitemid 17056428)
9. Hajto T., Lanzrein C., Natural killer and antibody-dependent cell-mediated cytotoxicity activities and large granular lymphocyte frequencies in Viscum album -treated breast cancer patients. Oncology 1986 43 2 93 97 2-s2.0-0022614078 (Pubitemid 16148623)
10. Bussing A., Mistletoe therapy and immunological research. Anti-Cancer Drugs 1997 8 1 S65 2-s2.0-0030994163 (Pubitemid 27202395)
11. Stein G. M., Berg P. A., Mistletoe extract-induced effects on immunocompetent cells: in vitro studies. Anti-Cancer Drugs 1997 8 1 S39 S42 2-s2.0-0031009209 (Pubitemid 27202389)
12. Gabius H. J., André S., Kaltner H., Siebert H. C., von der Lieth C. W., Gabius S., The mistletoe myth: claims, reality and provable perspectives. Zeitschrift fur Arztliche Fortbildung 1996 90 2 103 110 2-s2.0-0029880096
13. Franz H., Mistletoe lectins and their A and B chains. Oncology 1986 43 1 23 34 2-s2.0-0022974277 (Pubitemid 17211614)
14. Elsasser-Beile U., Voss M., Schuhle R., Wetterauer U., Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro. Journal of Clinical Laboratory Analysis 2000 14 6 255 259 10.1002/1098-2825(20001212)14:6<255::AID- JCLA1>3.0.CO;2-J
15. Elsässer-Beile U., Lusebrink S., Grussenmeyer T., Wetterauer U., Schultze-Seemann W., Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes. Arzneimittel-Forschung 1998 48 12 1185 1189 2-s2.0-2542509033 (Pubitemid 29006241)
16. Hajto T., Berki T., Palinkas L., Boldizsar F., Nemeth P., Investigation of the effect of mistletoe (Viscum album L.) extract Iscador on the proliferation and apoptosis of murine thymocytes. Arzneimittelforschung 2006 56 6 441 446
17. Samtleben R., Hajto T., Hostanska K., Wagner H., Mistletoe lectins as immunostimulants (chemistry, pharmacology and clinic). Immunomodulatory Agents from Plants 1999 Basel, Switzerland Birkhäauser 223 241
18. Lee R. T., Gabius H. J., Lee Y. C., Ligand binding characteristics of the major mistletoe lectin. The Journal of Biological Chemistry 1992 267 33 23722 23727 2-s2.0-0027095973 (Pubitemid 23088177)
19. Ribéreau-Gayon G., Dumont S., Muller C., Jung M. L., Poindron P., Anton R., Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Letters 1996 109 1-2 33 38 2-s2.0-0030568057 10.1016/S0304-3835(96)04401-1 (Pubitemid 27026201)
20. Hajto T., Hostanska K., Weber K., Zinke H., Fischer J., Mengs U., Lentzen H., Saller R., Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo. Natural Immunity 1998 16 1 34 46 2-s2.0-0031794944 10.1159/000069428 (Pubitemid 28499445)
21. Hajto T., Hostanska K., Frei K., Rordorf C., Gabius H. J., Increased secretion of tumor necrosis factor interleukin 1, and interleukin 6 by human mononuclear cells exposed to β -galactoside-specific lectin from clinically applied mistletoe extract. Cancer Research 1990 50 11 3322 3326 2-s2.0-0025313821 (Pubitemid 20190139)
22. Pae H. O., Seo W. G., Oh G. S., Shin M. K., Lee H. S., Kim S. B., Chung H. T., Potentiation of tumor necrosis factor- induced apoptosis by mistletoe lectin. Immunopharmacology and Immunotoxicology 2000 22 4 697 709 2-s2.0-0033679213
23. Büssing A., Stein G. M., Pfüller U., Schietzel M., Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes. Anticancer Research 1999 19 3 1785 1790 2-s2.0-0345240932 (Pubitemid 29392738)
24. Eggenschwiler J., Patrignani A., Wagner U., Rehrauer H., Schlapbach R., Rist L., Ramos M. H., Viviani A., Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro. Arzneimittel-Forschung 2006 56 6 483 496 2-s2.0-33748674851 (Pubitemid 44763357)
25. Weber K., Mengs U., Schwarz T., Becker H., Lentzen H., Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice. Arzneimittel-Forschung 1996 46 12 1174 1178 2-s2.0-0030479526 (Pubitemid 27010604)
26. Savoie A., Lavastre V., Pelletier M., Hajto T., Hostanska K., Girard D., Activation of human neutrophils by the plant lectin Viscum album agglutinin-I: modulation of de novo protein synthesis and evidence that caspases are involved in induction of apoptosis. Journal of Leukocyte Biology 2000 68 6 845 853 2-s2.0-0033674183
27. Stettin A., Schultze J. L., Stechemesser E., Berg P. A., Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro. Klinische Wochenschrift 1990 68 18 896 900 2-s2.0-0025126336 10.1007/BF01649034 (Pubitemid 20288855)
28. Stein G. M., Berg P. A., Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract. European Journal of Medical Research 1999 4 5 169 177 2-s2.0-0033606187
29. Stein G. M., Pfüller U., Berg P. A., Recognition of different antigens of mistletoe extracts by anti-mistletoe lectin antibodies. Cancer Letters 1999 135 2 165 170 2-s2.0-0344359774 10.1016/S0304-3835(98)00301-2 (Pubitemid 29090329)
30. Gorter R. W., van Wely M., Reif M., Stoss M., Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals. Alternative Therapies in Health and Medicine 1999 5 6 37 48 2-s2.0-0347022147
31. Huber R., Eisenbraun J., Miletzki B., Adler M., Scheer R., Klein R., Gleiter C. H., Pharmacokinetics of natural mistletoe lectins after subcutaneous injection. European Journal of Clinical Pharmacology 2010 66 9 889 897 10.1007/s00228-010-0830-5
32. Bock P. R., Friedel W. E., Hanisch J., Karasmann M., Schneider B., Efficacy and safety of long-term complementary treatment with standardized european mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma/results of a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittel-Forschung 2004 54 8 456 466 2-s2.0-4344630940 (Pubitemid 39127428)
33. Matthes H., Friedel W. E., Bock P. R., Zanker K. S., Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. Current Molecular Medicine 2010 10 4 430 439 10.2174/156652410791317057
34. Ostermann T., Bussing A., Retrolective studies on the survival of cancer patients treated with mistletoe extracts: a meta-analysis. Explore 2012 8 5 277 281 10.1016/j.explore.2012.06.005
35. Kienle G. S., Glockmann A., Schink M., Kiene H., Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. Journal of Experimental and Clinical Cancer Research 2009 28 article 79 10.1186/1756-9966-28-79
36. Ostermann T., Raak C., Bussing A., Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer 2009 9 article 451 10.1186/1471-2407-9-451
37. Horneber M. A., Bueschel G., Huber R., Linde K., Rostock M., Mistletoe therapy in oncology. Cochrane Database of Systematic Reviews 2008 2 CD003297 10.1002/14651858.CD003297.pub2 (Pubitemid 351807369)
38. Kienle G. S., Kiene H., Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. European Journal of Medical Research 2007 12 3 103 119 (Pubitemid 46564000)
39. Grossarth-Maticek R., Kiene H., Baumgartner S. M., Ziegler R., Use of iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Alternative Therapies in Health and Medicine 2001 7 3 57 76 2-s2.0-0035004688
40. Lenartz D., Dott U., Menzel J., Schierholz J. M., Beuth J., Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Research 2000 20 3 2073 2076 2-s2.0-0033877281 (Pubitemid 30636185)
41. Steuer-Vogt M. K., Bonkowsky V., Ambrosch P., Scholz M., Nei A., Strutz J., Hennig M., Lenarz T., Arnold W., The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. European Journal of Cancer 2001 37 1 23 31 2-s2.0-0035146589 10.1016/S0959-8049(00)00360-9 (Pubitemid 32119356)
42. Bar-Sela G., Wollner M., Hammer L., Agbarya A., Dudnik E., Haim N., Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. European Journal of Cancer 2013 49 5 1058 1064 10.1016/j.ejca.2012.11.007
43. Mansky P. J., Grem J., Wallerstedt D. B., Monahan B. P., Blackman M. R., Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy. Integrative Cancer Therapies 2003 2 4 345 352 2-s2.0-0344393561 10.1177/1534735403259061 (Pubitemid 37444430)
44. http://pi.lilly.com/us/gemzar.pdf
45. Kaplan E. L., Meier P., Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958 53 282 457 481 10.1080/01621459.1958.10501452
46. Jonckheere A. R., A distribution-free k-sample test against ordered alternatives. Biometrika 1954 41 1-2 133 145